Immedica Pharma AB, TRB Chemedica AG, Pharmaselect Deutschland GmbH secures contract for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient dexamethasone (except implant), ATC S01BA01 for the time 01012025 - 31122026

Germany, Sept. 29 -- Germany based Immedica Pharma AB, TRB Chemedica AG, Pharmaselect Deutschland GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient dexamethasone (except implant), ATC S01BA01 for the time 01012025 - 31122026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....